Ya kamata marasa lafiya na arthritis su damu?
Wasu marasa lafiya na arthritis suna jin tsoro lokacin da aka tsara su. An san maganin miyagun ƙwayoyi ne don maganin ciwon daji. Amma, shin daidai ne don ƙayyade ko yin la'akari da yadda za a yi amfani da miyagun ƙwayoyi na chemotherapy idan an umurce shi don maganin cututtuka na rheumatoid? Wataƙila wannan ya zama kamar wata tambaya mai mahimmanci ga wasu, amma idan rashin kuskure ya sa tsoro ko kuma ya hana marasa lafiya daga yin amfani da miyagun ƙwayoyi wanda zai iya taimaka musu, wannan tambayar yana da mahimmanci.
Bari mu bincika gaskiyar.
Amsaccen Amsa
Fiye da shekaru 50 da suka gabata, an gabatar da methotrexate a matsayin magani ga ciwon daji saboda sakamakon da ya haifar da cutar. A cikin shekaru 25 da suka wuce, an yi amfani da miyagun ƙwayoyi ne a matsayin magungunan anti-rheumatic mai cuta (DMARD) don magance cututtuka na rheumatoid da wasu cututtuka na rheumatic. Anyi la'akari da Methotrexate a matsayin magani na zinariya, ko magani na zabi, a cikin maganin cututtuka na rheumatoid.
Bisa ga wani babi a kan DMARDs a cikin littafin, Rheumatoid Arthritis: Binciken Binciken Farko da Kulawa , "Ganinsa ya kasance tare da sauƙi na yin amfani da shi (na baka ko na sashi, mako-mako dosing), ƙayyadaddun ƙwayoyin cuta, sauƙi na farko na amfanin asibiti (yawanci a cikin 6 zuwa makonni takwas), dadiyar kuɗi, kuɗi mai yawa, karin amfani idan an hade tare da sauran DMARD tsarin, da kuma ikon iya jinkirta lalacewar labaru. "
Ta yaya Methotrexate Works?
Wadanda aka ambata sunyi zaton sun kasance sun danganci haɗin ginadarin dihydrofolate reductase da samar da acid.
Lokacin da aka yi amfani dashi a matsayin DMARD, amfani da hanyoyin da aka kwatanta da haɓaka adenosine, duk da haka, wanda shine mai matsakanci mai ƙin kumburi. Don inganta yanayin tasiri a kan samar da acid, yawancin yau da kullum tare da folic acid wani ɓangare ne na tsarin al'ada ga marasa lafiya na rheumatic.
Idan aka yi amfani dashi a matsayin wakili na chemotherapy, hanya ta hana kwayoyin halitta ta yin amfani da furotin don yin DNA da RNA, saboda haka jinkirin ci gaban kwayoyin cutar ciwon daji.
Ƙananan magani da aka buƙata a matsayin DMARD
Lokacin da aka yi amfani da shi azaman magani na chemo, ana ba da hanya a matsakaici zuwa matsakaicin matsakaici. Yanayin ya ƙayyade yawan ƙarfin mai haƙuri, irin ciwon daji da ake bi da shi, da aikin koda. Yawanci fiye da ko kuma daidai da 500mg / m2 suna dauke da high, yayin da allurai 50 zuwa 500 mg / m2 su ne matsakaici. Ana daukar kashi kashi kadan a ƙarƙashin 50 MG / m2.
Lokacin da ake amfani da hanya don bi da cututtuka na rheumatoid, an dauki kashi a matsayin ƙananan - yawanci yakan fara daga 7.5 zuwa 10 MG / mako. Idan an buƙata, za a iya ƙara yawan kashi a ƙara zuwa matsakaicin 25 MG / mako.
Idan tasiri ko cututtuka suka ci gaba, an ji cewa ragewar kashi ko sauyawa daga murya zuwa hanya mai inganci zai iya sarrafa al'amura. Anyi amfani da gwaje-gwaje na jini a kan marasa lafiya da ke bin ka'idodi (cikakkun jini, hanta da kuma kididdigar koda) don gano matsaloli a farkon don a iya gyarawa. Idan rare, manyan abubuwan da suka faru na mummunan ci gaba, ƙarewar hanya zai zama wajibi.
Layin Ƙasa
Lokacin da aka nema don yin sharhi game da ko methotrexate ya kamata a ji tsoronsa saboda ana amfani dashi azaman kumburiya, masanin rheumatologist Scott J.
Zashin, MD (www.scottzashinmd.com/) ya amsa ya ce, "Yayin da za'a iya amfani da samfurori a cikin dogaro ga chemo, masu rheumatologists suna amfani da ƙananan hanya saboda ƙananan kariya masu kariya. hulɗar juna tsakanin NSAIDs (maganin na yau da kullum don cututtukan maganin rheumatoid) da kuma methotrexate amma ba a ji su zama haɗuwa da ƙwayoyin cuta ba tare da ƙananan kashi na magani da aka yi amfani da shi don maganin cutar wariyar launin fata. Ya kamata marasa lafiya su tuna cewa an ba da magani don a ɗauka kawai sau ɗaya a mako guda don rage iyakokin tasiri. "
Sources:
Arthritis Rheumatoid: Sanin asali da Jiyya. Cush, Weinblatt, da Kavanaugh. Buga na Uku. Babi na 11 - Cigaban Magungunan ƙwayar cuta.
Amfani da ilimin likitanci da maɗaukaki na Tsarin Tsarin Mulki. Ann S. LaCasce, MD. Na zamani. Binciken Nuwamba 2013.
Methotrexate. Cibiyar Cancer na Amurka. 12/29/2011.